Vikash Reebye
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.
Journal: Frontiers in medicine
Published: February 18, 2026
Concerted Action of Targeted Nucleic Acid Therapeutics as Flexible, Precision and Personalized Cancer Treatment.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 14, 2025
GalNAc-conjugated siRNA targeting C/EBPβ reverses metabolic dysfunction and restores liver homeostasis in a murine MASLD model.
Journal: Molecular therapy. Nucleic acids
Published: October 23, 2025
Erratum: RNA activation of CEBPA improves leukemia treatment.
Journal: Molecular therapy. Nucleic acids
Published: September 22, 2025
Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.
Journal: Oncogene
Published: May 07, 2025
RNA activation of CEBPA improves leukemia treatment.
Journal: Molecular therapy. Nucleic acids
Published: December 24, 2024
Design and Evaluation of RNA Aptamer-Mediated Delivery of C/EBPβ siRNA for Oncological Therapy.
Journal: Journal of nucleic acids
Published: October 06, 2024
The Effect of Interleukin-10 Immunotherapy on Renal Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Studies.
Journal: International journal of molecular sciences
Published: April 17, 2024
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.
Journal: Cell reports. Medicine
Published: November 16, 2023
Cannabidiol's cytotoxicity in pancreatic cancer is induced via an upregulation of ceramide synthase 1 and ER stress.
Journal: Journal of cannabis research
Published: October 20, 2023
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome.
Journal: Nucleic acid therapeutics
Published: July 27, 2022
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models.
Journal: International journal of molecular sciences
Published: July 25, 2021
Last Updated: 09/26/2026